Sputnik V Covid-19 Vaccine Recommended For Emergency Use in India
According to the latest reports, Russia's Covid-19 vaccine Sputnik V has been recommended for emergency use in India by the Subject Expert Committee. If approved by the Drug Controller General of India, Sputnik V will become the third Covid-19 vaccine available in the country. It must be noted that Russia's Sputnik V was the first coronavirus vaccine to receive regulatory approval from any country in the world. The coronavirus vaccine has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Russia.
You May Also Check: Covid-19 Health Insurance
Sputnik V, the potential third coronavirus vaccine in India is being marketed by Dr. Reddy's Laboratories in the country. It must be noted that Dr. Reddy's Laboratories partnered with Russian Direct Investment Fund (RDIF) and conducted clinical trials in India in September 2020 so as to test the safety and ability to generate an immune response.
As per the Russian health ministry, Sputnik V is a unique ‘two-vector vaccine', that uses two different adenovirus vector types, rAd26 for the first shot, and rAd5 for the second for an enhanced efficiency. The two shots of the coronavirus vaccine are given to the patient at a gap of third-weeks.
According to results published in the Lancet in February 2021, Russia's Sputnik V vaccine is 91.6% effective against symptomatic coronavirus disease. Alexander Gintsburg, Director, Gamaleya National Research Centre, confirmed earlier that Sputnik V has proven equally effective for all age groups.
Russia’s novel coronavirus vaccine Sputnik V has already been registered in several countries across the globe, including Belarus, Venezuela, Bolivia and Algeria as per Russian Direct Investment Fund. RDIF has signed deals for production of more than 750 million doses of Sputnik V with six domestic firms in India.
You May Also Like To Read:
Things to Know About a COVID-19 Vaccine
Coronavirus Vaccine: What You Can And Cannot Do After Getting Vaccinated?
Disclaimer: This article is issued in the general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.
